The family of
interleukin-17 (IL-17)
cytokine is the essential inflammatory mediator that influences the pathophysiology of various inflammatory diseases. Many studies focused on investigating the expression, signaling, and biological impacts of
IL-17A and
IL-17F, and the neutralization of these
cytokines exhibited some promising results in clinical trials. In contrast, the expression resources and physiological relevance of
IL-17C remained to be studied. In this study, through a microarray approach conducted with nontransformed human colonic epithelial cells (NCM460), we found that bacterial
flagellin stimulation elicited potent
IL-17C mRNA expression. We also confirmed that
IL-17C protein production was strongly induced by
flagellin in these cells.
Flagellin-induced
IL-17C expression was also observed in human
colon adenocarcinoma cells such as DLD-1 and HT-29, indicating that
IL-17C could be a signature inflammatory
cytokine from intestinal epithelial cells in response to
flagellin. Since inhibited in TLR5-, or MyD88- or TRIF-silenced cells,
flagellin-induced
IL-17C expression was specifically mediated by TLR5 and, subsequently, MyD88 and TRIF adaptor molecules. Furthermore, in line with inflammatory nature of
IL-17, we found that
IL-17C expression was substantially enhanced in the intestinal tissues from
Ulcerative colitis patients. Given the facts that TLR5 is a key
pattern recognition receptor which mediates microbial recognition in the intestinal epithelium and
IL-17C turned out to be a unique member of the
IL-17 family expressed in intestinal epithelial cells on TLR5 activation, our study may provide an important clue on understanding how intestinal microbes would contribute to an inflammatory program in the gut.